MINNEAPOLIS, July 16 /PRNewswire/ -- In a statement released today, Bud Hayden, a director serving as interim CEO of Bioenergy, Inc., a privately held Minneapolis-based integrative life science company, announced Raj Khankari, PhD, will join the company as its new CEO on August 1, 2008.
Dr. Khankari joins the company from CIMA Labs Inc., a Cephalon company, where he served as General Manager, CIMA Labs Inc., and Vice President for Worldwide Drug Delivery Technologies. Dr. Khankari earned his initial degrees in Pharmaceutics from universities in India. Dr. Khankari also has a PhD in Pharmaceutics and an MBA from the University of Minnesota.
In addition to holding several patents, Dr. Khankari has been widely published in several peer reviewed journals and has been a presenter at more than two dozen national and international meetings.
In making the announcement, Mr. Hayden stated, "We are very pleased to have Dr. Khankari head up our Company. His scientific background, including his successful track record in working with the Food and Drug Administration (FDA) on new product discoveries, in conjunction with the experience he gained in holding senior management positions, will provide the leadership Bioenergy needs to take advantage of our strong intellectual property portfolio."
In addition to its pharmaceutical subsidiary company, Bioenergy has two other subsidiaries. Bioenergy Life Science, Inc. manufactures and sells D-ribose as an ingredient to nutraceuticals firms marketing beverages and foods, as a medical food through doctors and clinics and as a dietary supplement for energy recovery (reduces fatigue, muscle pain, soreness and stiffness following exercise). Viacell, LLC is engaged in developing technology related to the enhancement of blood components.
D-Ribose is a naturally occurring monosaccharide the body uses to stimulate the synthesis of adenosine triphosphate (ATP), an essential energy compound. ATP is critical to health and maintaining normal energy-dependent body functions. Ribose is an essential component in the cellular production of ATP.
D-Ribose has been shown to increase functional capacity for patients with congestive heart failure (CHF) by improving diastolic heart function, ventilation, exercise capacity, and oxygen uptake efficiency. It's also widely used to help treat Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS). D-ribose is commonly found in more and more functional foods like energy bars (e.g., Detour, FastFuel, Marathon) and drinks (e.g., Vitamin Water, SoBe Life Water, Snapple Antioxidant Water).
Bioenergy, Inc. (http://www.bioenergy.com) is a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-ribose in health and wellness.
CONTACT: Dean Draznin, +1-641-472-2257, email@example.com, or Leslie
Levine, +1-847-205-9853, firstname.lastname@example.org, both for Bioenergy, Inc.
Web site: http://www.bioenergy.com/